Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS.

Autor: Courbis AL; LGI2P, IMT Mines Ales, University of Montpellier, Ales, France., Murray RB; Department of Allergic Diseases, Medscript NZ Ltd, Paraparaumu Beach, Kapiti Coast, New Zealand., Arnavielhe S; Kyomed, Montpellier, France., Caimmi D; Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France., Bedbrook A; Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France., Van Eerd M; Peercode B.V., Geldermalsen, The Netherlands., De Vries G; Peercode B.V., Geldermalsen, The Netherlands., Dray G; LGI2P, IMT Mines Ales, University of Montpellier, Ales, France., Agache I; Transylvania University Brasov, Brasov, Romania., Morais-Almeida M; Immunoallergy Department, CUF Descobertas Hospital, Lisbon, Portugal., Bachert C; ENT Department, Upper Airways Research Laboratory, Ghent University Hospital, Ghent, Belgium., Bergmann KC; Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany., Bosnic-Anticevich S; Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, New South Wales, Australia., Brozek J; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada., Bucca C; Hospital City of Health and Science of Torino, University Pneumology Unit-AOU Molinette, Turin, Italy., Camargos P; Department of Pediatrics, Medical School, Federal University of Minas Gerais, Belo Horizonte, Brazil., Canonica GW; Personalized Medicine Asthma & Allergy Clinic, Humanitas University & Research Hospital, Milan, Italy., Carr W; Allergy and Asthma Associates of Southern California, Mission Viejo, California, USA., Casale T; Division of Allergy and Immunology, University of South Florida Morsani College of Medicine, Tampa, Florida, USA., Fonseca JA; CINTESIS, Faculdade de Medicina da Universidade do Porto & MEDIDA, LDA, Porto, Portugal., Haahtela T; Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland., Kalayci O; Department of Pediatric Allergy, Hacettepe University School of Medicine, Ankara, Turkey., Klimek L; Center for Rhinology and Allergology, Wiesbaden, Germany., Kuna P; Barlicki University Hospital, Medical University of Lodz, Lodz, Poland., Kvedariene V; Department of Pathology, Faculty of Medicine, Clinic of Infectious, Chest Diseases, Dermatology and Allergology, Institute of Biomedical Sciences, Vilnius University, Vilnius, Lithuania., Larenas Linnemann D; Clínica de Alergia, Asma y Pediatría, Hospital Médica Sur, Mexico City, Mexico., Lieberman P; Divisions of Allergy and Immunology, Department of Internal Medicine and Pediatrics, University of Tennessee College of Medicine, Germantown, Tennessee, USA., Mullol J; ENT Department, Hospital Clinic, Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, Universitat de Barcelona, Barcelona, Spain., Ohehir R; Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia., Papadopoulos N; Division of Infection, Immunity & Respiratory Medicine, University of Manchester, Manchester, UK.; Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece., Price D; Observational and Pragmatic Research Institute, Singapore, Singapore., Ryan D; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh Medical School, Edinburgh, UK., Samolinski B; Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland., Simons FE; Department of Pediatrics and Child Health, Department of Immunology, Faculty of Medicine, University of Manitoba, Winnipeg, Winnipeg, Canada., Tomazic P; Department of ENT, Medical University of Graz, Graz, Austria., Triggiani M; Division of Allergy and Clinical Immunology, University of Salerno, Salerno, Italy., Valiulis A; Department of Public Health, Institute of Clinical Medicine, Clinic of Children's Diseases, Institute of Health Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Valovirta E; Department of Lung Diseases and Clinical Allergology, University of Turku, Turku, Finland.; Allergy Clinic, Terveystalo, Turku, Finland., Wagenmann M; Department of Otorhinolaryngology, HNO-Klinik, Universitätsklinikum Düsseldorf, Düsseldorf, Germany., Wickman M; Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden., Yorgancioglu A; Department of Pulmonology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey., Bousquet J; Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.; INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France.; UMR-S 1168, Université Versailles St-Quentin-en-Yvelines, Montigny le Bretonneux, France.; CHU Montpellier, Montpellier, France.
Jazyk: angličtina
Zdroj: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2018 Dec; Vol. 48 (12), pp. 1640-1653. Date of Electronic Publication: 2018 Aug 20.
DOI: 10.1111/cea.13230
Abstrakt: Background: Allergic rhinitis (AR) management has changed in recent years following the switch from the concept of disease severity to the concept of disease control, publication of the AR clinical decision support system (CDSS) and development of mobile health (m-health) tools for patients (eg Allergy Diary). The Allergy Diary Companion app for healthcare providers is currently being developed and will be launched in 2018. It incorporates the AR CDSS to provide evidence-based treatment recommendations, linking all key stakeholders in AR management.
Objective: To produce an electronic version of the AR CDSS (e-CDSS) for incorporation into the Allergy Diary Companion, to describe the app interfaces used to collect information necessary to inform the e-CDSS and to summarize some key features of the Allergy Diary Companion.
Methods: The steps involved in producing the e-CDSS and incorporating it into the Allergy Diary Companion were (a) generation of treatment management scenarios; (b) expert consensus on treatment recommendations; (c) generation of electronic decisional algorithms to describe all AR CDSS scenarios; (d) digitization of these algorithms to form the e-CDSS; and (e) embedding the e-CDSS into the app to permit easy user e-CDSS interfacing.
Results: Key experts in the AR field agreed on the AR CDSS approach to AR management and on specific treatment recommendations provided by Allergy Diary Companion. Based on this consensus, decision processes were developed and programmed into the Allergy Diary Companion using Titanium Appcelerator (JavaScript) for IOS tablets. To our knowledge, this is the first time the development of any m-health tool has been described in this transparent and detailed way, providing confidence, not only in the app, but also in the provided management recommendations.
Conclusion: The Allergy Diary Companion for providers provides guideline and expert-endorsed AR management recommendations. [MASK paper No 32].
(© 2018 John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje